Eisai

Pharma

Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia

Pfizer joined the PD-1xVEGF bispecific race. The FDA approved its first Alzheimer's blood test. Samsung Biologics plans a biosimilar spinoff. And more.

Angus Liu May 23, 2025 9:00am

New Alzheimer's test will take time to boost Leqembi: analyst

May 19, 2025 1:52pm

Eisai mounts targeted TV ad push to raise awareness of Leqembi

May 19, 2025 12:26pm

Trump's tariffs, Leqembi, Kyowa Kirin—Fierce Pharma Asia

Apr 18, 2025 9:25am

Eisai and Biogen's Alzheimer's med Leqembi approved in Europe

Apr 16, 2025 7:52am

Pharmas' Xi meeting; Tariffs; BioNTech—Fierce Pharma Asia

Apr 4, 2025 8:30am